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resectable and if metastatic disease is absent. Chemotherapy and radiation therapy are used to treat tumors that are unresectable because of intrathoracic spread or distant metastases. Small cell lung cancer (SCLC), which metastasizes early and has a worse outcome than NSCLC, has a separate staging system. [1] [2] [3] Lung cancer has one of the lowest survival outcomes of any cancer because over two-thirds of patients are diagnosed at a late stage when curative treatment is not possible. 4 Despite the advances in imaging techniques and treatment modalities, the prognosis of lung cancer remains poor, with five-year survival of 14% at early stages and less than 5% in locally advanced stages. 5 In our country the patients mainly attended the hospital at the late stage of the disease. Main reason for late presentation is poor health awareness, delayed recognition and poor referral to the specialized centre.
This study was undertaken to analysis the demographic pattern, clinical presentation, and pathological characteristics of lung cancer as well as the outcome of chemotherapy used in Lung cancer patients.
Materials and methods:
In one year (1st Jan 08 -31st Dec 08), the diagnosed lung cancer patients who had faced the multidisciplinary tumor board of National Institute of Cancer Research and Hospital, Dhaka, Bangladesh and selected for chemotherapy or palliative care were registered in the Dept. of Medical Oncology. Each patient was interviewed according to a preformed questionnaire. The particulars of the patients, complete clinical history, previous treatment record specially already done surgical notes, radiological and imaging study, histopathology report, complete blood count, liver function, kidney function test, other biochemical laboratory studies, tumor marker were documented in the record file. The patients were categorized into operated and inoperable group. According to performance status, hematological parameters, cardiac function, liver function, kidney function test, chemotherapy was prescribed and carried out. The patients unfit for chemotherapy were treated symptomatically. After completion of the chemotherapy, the patients were advised for follow up six/eight weekly. Those who are only supportive and symptomatic care were advised to come whenever they faced the deteriorating sign symptoms. All the documents were compiled with patients database accordingly. Ethical clearance was taken from the ethical review committee and informed writhen consent was taken from each patient.
Result:
Total 701 lung cancer patients attended: male-608 and female-93; male to female ratio-6.15:1; age range 25 years to 95 years and mean age 62 years; more than 85% of the patients at and above 50 years. The patients are illiterate (44%) and belonged to poor families (13%) and bellow average families (70%). Occupationally male patients were farmer (71%) and all females were housewife ( Table-I) . Table-I ).
After attending the department, 45% of female patients and 30% of male patients dropped out out after first and second visit, 48% of male and 32% of female were treated by chemotherapy and the remaining around 20% of both sexes were treated by supportive and symptomatic treatment. Chemotherapy was effective. About 10% of them showed complete clinical and radiological response and others benefited with some sorts of symptoms relief and radiological improvement. The result of the study is given in tables and charts. All most all patients presented with anorexia and weight loss. Figure-1 Total 326 lung cancer patients were treated by chemotherapy. The patients were evaluated between 3 moths to 6 months of treatment. They were categorized into A,B,C,D,&E according to symptoms relief, weight gain and treatment response (Fig.-II) .
A=Complete relief of symptoms, weight gain, radiological disappearance of lung lesion.
B= Complete relief of symptoms, weight gain, radiological improvement of lung lesion C= Partial relief of symptoms, weight gain, radiological improvement of lung lesion
Discussion:
The lung cancer is number one cancer problem comprising of 16.7% of all cancers of Bangladeshi people 3 . In our study, there was male preponderance (81.56%) as compared with female (13%). This picture is more or less similar with India. 6 Increasing age is a risk factor for lung cancer. It is less common in people under age 40. More diagnoses occur after age 45 and a larger number over age 65 years. 8 In the present study, common occurrence of this disease was found at and after 50 years and least common (1.42%) before 40. On risk assessment, it had been found that more than 90% of our patients were habituated with smoking, betel nut tobacco sewing and gull user (tobacco leaf powder used in root of teeth). Though around 20% of female patient was smoker but 62% of them had the long history of betel nut tobacco sewing and gull use. Sixteen patients had the cuteneous sign of arsenicosis. Smoking is an established cause of lung cancer. Regarding occupation, more than 70% of our study male patient was farmer, 74 service holder (12%), 22 patients were motor vehicle drivers and 34 day labor workers mainly worked in building construction, painting, and carpenter (Table-I ). The above-mentioned occupations are considered as exposed workers for lung cancer in different studies. 9 There was increased risked of lung cancer for the exposed workers 10 .
There are two main types of lung cancer; non-small cell lung cancer (NSCLC) 80.4% and small cell carcinoma (SCLC) 16.8 percent. 11 In the present study, NSCLC was 81.45% and SCLC 18.55%. The World Health Organization classification for primary lung cancer recognizes four major histologic cell types such as adenocarcinoma, squamous cell carcinoma, small cell carcinoma and large cell carcinoma. Squamous cell carcinoma (SCC) was the most frequent histologic type of lung tumor in nearly all studies done prior to the mid-1980s. More recent reports have noted a shift in the relative frequency of lung carcinoma tumor types such that adenocarcinoma now is more common than squamous cell carcinoma, particularly in women. 12 In our study, squamous cell carcinoma was most frequent (43.42% ) type among the males but in females, 55.92% lung cancer was adenocarcinoma (Figure-1 ).
An analysis of the presenting symptoms, cough and expectoration was most common (29.24%), cough and chest pain (20%) and mixed symptoms in 18% of the patients ( Lung cancer remains highly lethal disease. In United States, five-year survival is 15%, best recorded at population level, average survival in Europe is 10%, not much better than 8.9% in developing countries. 1 The situation is similar in India. The published reports do not mention about the fiveyear survival rate. One-year survival has been 9.8 percent. 14 In the present study, about one-third of male and 45% of female patients drop out after first and second visit due to advanced stage, poor performance status and poor socioeconomic condition.
Because of the advanced stage of the disease, the only option is the systemic chemotherapy. Radiotherapy can be used as an adjuvant and localized form of treatment. It is well established that chemotherapy is better than best supportive care 15, 16 . In the present study, 326 patients were treated by chemotherapy according to standard schedule (Table . 3). About 10% of the patients showed complete response (symptomatic and radiological) and others benefited with some sorts of symptomatic improvement. (Figure. 2).
Our study revealed that, lung cancer patients attended at inoperable stage with male preponderance bearing performance status WHO grade 2 and grade 3 in 70% of cases. Squamous cell carcinoma (43.42%) was the most common type in male but adenocarcinoma (55.92%) in female. One third of male and 45% of female patients drop out, around 20% of both sexes received supportive and symptomatic treatment; chemotherapy was carried out in 48.68% of male and 32.26% of female patients. Chemotherapy was effective with some sorts of symptoms relief in all most all patients.
In conclusion, it can be commented that the lethal nature of lung cancer is overlooked. We need to focus more on its prevention as treatment modalities are limited.
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